All Comments by Benjamin Wolozin

  1. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.
  2. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
  3. Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.
  4. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.
  5. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.
  6. Statins and the risk of dementia.
  7. A novel peptide prevents death in enriched neuronal cultures.
  8. Alzheimer's disease: model behaviour.
  9. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
  10. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
  11. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.
  12. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.
  13. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
  14. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
  15. Cholesterol Again Linked with Alzheimer's